Immunovant, Inc. (IMVT) Misses Q3 EPS by 10c

Immunovant, Inc. (NASDAQ: IMVT) reported Q3 EPS of ($0.49), $0.10 worse than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
• Darling Ingredients (DAR) PT Raised to $88 at UBS